About AVT
Browse Articles
Authors
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 19 Issue 3 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 1803 results:

Short communication

Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting

Antonella d’Arminio Monforte, Nicola Gianotti, Alessandro Cozzi-Lepri, Carmela Pinnetti, Massimo Andreoni, Giovanni di Perri, Massimo Galli, Andrea Poli, Andrea Costantini, Giancarlo Orofino, Franco Maggiolo, Giovanni Mazzarello, Benedetto Maurizio Celesia, Filippo Luciani, Adriano Lazzarin, Laura Sighinolfi, Giuliano Rizzardini, Paolo Bonfanti, Carlo Federico Perno, Andrea Antinori, the ICONA Foundation Cohort

Antiviral Therapy 2014; 19:319-324


Original article

Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals

Jennifer Gillis, Marek Smieja, Angela Cescon, Sean B Rourke, Ann N Burchell, Curtis Cooper, Janet M Raboud, the OHTN Cohort Study Group

Antiviral Therapy 2014; 19:309-317


Free
Original article

A systematic review of the use of atazanavir in women infected with HIV-1

Margaret Johnson, Sharon Walmsley, Annette Haberl

Antiviral Therapy 2014; 19:293-307


Original article

Liver fibrosis progression in HIV–HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapy

José V Fernández-Montero, Pablo Barreiro, Eugenia Vispo, Pablo Labarga, Clara Sánchez-Parra, Carmen de Mendoza, Ana Treviño, Vicente Soriano

Antiviral Therapy 2014; 19:287-292


Original article

Telaprevir is effective given every 12 h at 750 mg with pegylated interferon-α2b and ribavirin to Japanese patients with HCV-1b IL28B rs8099917 TT

Yoshiiku Kawakami, Fumitaka Suzuki, Yoshiyasu Karino, Joji Toyota, Hiromitsu Kumada, Kazuaki Chayama

Antiviral Therapy 2014; 19:277-285


Original article

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial

Victor Musiime, Adrian Cook, Joshua Kayiwa, Dorothy Zangata, Carol Nansubuga, Beatrice Arach, Julia Kenny, Priscilla Wavamunno, Justine Komunyena, Desiree Kabamba, Alice R Asiimwe, Grace Mirembe, George Abongomera, Veronica Mulenga, Adeodata Kekitiinwa, Cissy Kityo, Sarah A Walker, Nigel Klein, Diana M Gibb, the CHAPAS-3 trial team

Antiviral Therapy 2014; 19:269-276


Original article

Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir

Annikki de Niet, Louis Jansen, Hans L Zaaijer, Ursula Klause, Bart Takkenberg, Harry LA Janssen, Tom Chu, Rosemary Petric, Hendrik W Reesink

Antiviral Therapy 2014; 19:259-267


Original article

Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies

Victoria Arama, Hakan Leblebicioglu, Krzysztof Simon, Jean Pierre Zarski, Claus Niederau, François Habersetzer, Johannes Vermehren, Wieslawa Bludzin, Mariana Jinga, Sercan Ulusoy, Isabelle Klauck, Edith Morais, Stefan Bjork, Benedicte Lescrauwaet, Driss Kamar, Stefan Zeuzem, the AI463-121 European Longitudinal Chronic Hepatitis B Study Group

Antiviral Therapy 2014; 19:245-257


Original article

Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study

Patrick Marcellin, Victoria Arama, Hakan Leblebicioglu, Jean Pierre Zarski, Stefan Zeuzem, Stefan Mauss, Jerzy Sieklucki, Monica Acalovschi, Gaye Usluer, Isabelle Klauck, Edith Morais, Stefan Bjork, Benedicte Lescrauwaet, Driss Kamar, Krzysztof Simon, the AI463-121 European Longitudinal Chronic Hepatitis B Study Group

Antiviral Therapy 2014; 19:235-243


Free
Original article

Relative bioavailability of a paediatric granule formulation of the HIV integrase inhibitor dolutegravir in healthy adult subjects

Parul Patel, Ivy Song, Julie Borland, Shuguang Chen, Amanda Peppercorn, Toshihiro Wajima, Takeshi Funaki, Naomi Fujita, John Hughes, Stephen Piscitelli

Antiviral Therapy 2014; 19:229-233


Page:
Copyright © Nucleus Global 2014. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.